Cognitive impairment (CI) is a significant symptom of multiple sclerosis (MS), is the strongest predictor of unemployment in MS patients, and is critical to the decline of quality of life. There is an unmet need for imaging techniques that probe the pathological substrate of CI at a clinically relevant field strength. To address this need, we have investigated the translation of glutamate-sensitive chemical exchange saturation transfer (GluCEST) MRI to 3T, as glutamate abnormalities have been linked to CI in MS. Our results demonstrate the clinical feasibility of GluCEST imaging for application to studying cortical gray matter glutamate signals in vivo.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords